Avanos Medical Inc (AVNS)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 63.37% | 62.09% | 60.08% | 57.97% | 57.67% | 51.67% | 51.44% | 50.35% | 49.39% | 48.39% | 49.27% | 51.22% | 53.04% | 56.11% | 57.09% | 58.08% | 58.92% | 59.22% | 61.33% | 62.40% |
| Operating profit margin | 2.08% | 7.73% | 8.91% | 10.05% | 10.69% | 7.42% | 6.36% | 4.18% | 1.44% | -8.69% | -9.19% | -8.75% | -6.94% | -0.64% | -3.27% | -4.37% | -8.16% | -9.16% | -5.44% | -2.68% |
| Pretax margin | -9.42% | -4.87% | -3.06% | 7.57% | 8.44% | 8.08% | 6.68% | 3.80% | 0.98% | -9.41% | -10.38% | -10.54% | -8.99% | -2.79% | -5.18% | -5.89% | -9.38% | -10.01% | -6.26% | 0.83% |
| Net profit margin | -9.97% | -7.54% | -4.69% | 5.56% | 6.23% | 5.72% | -0.76% | 2.65% | 0.85% | -7.41% | 0.05% | -5.85% | -4.15% | 1.98% | -2.45% | -3.14% | -6.72% | -6.33% | -4.01% | 2.66% |
The profitability ratios of Avanos Medical Inc have shown fluctuating trends over the past eight quarters.
1. Gross Profit Margin: The company's gross profit margin has been relatively stable, ranging from 54.88% to 56.39%. This indicates that Avanos Medical Inc has been able to maintain a solid level of profitability after accounting for the cost of goods sold.
2. Operating Profit Margin: The operating profit margin shows a varying trend, with the highest value of 9.45% in Q4 2022 and the lowest at 2.60% in Q4 2023. This suggests that the company's operational efficiency and cost controls have fluctuated over the period.
3. Pretax Margin: Avanos Medical Inc's pretax margin has also been inconsistent, with negative values in Q4 2023 and positive values ranging from 3.53% to 8.13% in the other quarters. This indicates that the company's ability to generate profits before taxes has shown some volatility.
4. Net Profit Margin: The net profit margin has been negative in Q1-Q3 of 2023 and Q2 2022, with the highest positive value of 6.16% in Q4 2022. This suggests that the company's overall profitability after all expenses, including taxes, has varied significantly over the analyzed period.
Overall, the analysis of Avanos Medical Inc's profitability ratios indicates a mixed performance in terms of generating profits and managing costs, with some quarters showing stronger profitability than others.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 0.76% | 3.29% | 4.10% | 4.65% | 4.85% | 3.30% | 2.80% | 1.79% | 0.67% | -3.97% | -3.98% | -3.73% | -2.90% | -0.25% | -1.28% | -1.73% | -3.10% | -3.36% | -2.00% | -0.93% |
| Return on assets (ROA) | -3.65% | -3.21% | -2.16% | 2.57% | 2.83% | 2.54% | -0.34% | 1.14% | 0.39% | -3.39% | 0.02% | -2.49% | -1.73% | 0.77% | -0.96% | -1.24% | -2.55% | -2.32% | -1.47% | 0.93% |
| Return on total capital | -3.51% | -1.73% | -0.85% | 5.61% | 5.17% | 5.65% | 4.54% | 2.58% | 0.76% | -4.50% | -4.57% | -4.33% | -3.28% | -0.19% | -1.53% | -2.03% | -3.22% | -3.45% | -1.72% | 1.74% |
| Return on equity (ROE) | -5.00% | -4.53% | -2.92% | 3.43% | 3.91% | 3.57% | -0.47% | 1.59% | 0.50% | -4.28% | 0.03% | -3.27% | -2.30% | 1.08% | -1.34% | -1.74% | -3.61% | -3.32% | -2.06% | 1.33% |
Avanos Medical Inc's profitability ratios present a mixed performance over the past quarters. The Operating Return on Assets (Operating ROA) has shown a declining trend from Q1 2023 to Q4 2023, indicating decreasing efficiency in generating profits from its assets. The Return on Assets (ROA) also witnessed a fluctuating pattern, with negative values in the last three quarters, suggesting challenges in generating profits from its total assets.
On the other hand, the Return on Total Capital and Return on Equity (ROE) have generally shown an upward trend from Q1 2022 to Q4 2023, indicating an improvement in the company's ability to generate returns for both capital providers and equity shareholders.
Overall, Avanos Medical Inc's profitability ratios reflect a combination of strengths and weaknesses. The company may need to focus on enhancing operational efficiency and optimizing asset utilization to improve profitability in the upcoming periods.